These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36794164)

  • 1. Aberrant alteration of peripheral B lymphocyte subsets in hepatocellular carcinoma patients.
    Wu J; Wang Y; Bai S; Sun H; Zhang J; Shu J; Wang Y; Tan M; Zhou L; Huang B; Pan Q; Sheng H
    Int J Med Sci; 2023; 20(2):267-277. PubMed ID: 36794164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Peripheral B-Lymphocyte Subsets in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults.
    Deng C; Xiang Y; Tan T; Ren Z; Cao C; Huang G; Wen L; Zhou Z
    Diabetes Care; 2016 Mar; 39(3):434-40. PubMed ID: 26721817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and Implications of myeloid-derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma.
    Hetta HF; Zahran AM; Mansor SG; Abdel-Malek MO; Mekky MA; Abbas WA
    J Med Virol; 2019 Jul; 91(7):1319-1328. PubMed ID: 30761547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.
    Cho EB; Cho HJ; Seok JM; Min JH; Kang ES; Kim BJ
    Neurol Sci; 2018 Mar; 39(3):543-549. PubMed ID: 29349658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered cytokine levels and increased CD4+CD57+ T cells in the peripheral blood of hepatitis C virus-related hepatocellular carcinoma patients.
    Shiraki T; Takayama E; Magari H; Nakata T; Maekita T; Enomoto S; Mori Y; Shingaki N; Moribata K; Deguchi H; Ueda K; Inoue I; Mizuno-Kamiya M; Yashiro K; Iguchi M; Tamai H; Kameyama Y; Kato J; Kondoh N; Ichinose M
    Oncol Rep; 2011 Jul; 26(1):201-8. PubMed ID: 21491089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in immune profile affect disease progression in hepatocellular carcinoma.
    Fathi F; Saidi RF; Banafshe HR; Arbabi M; Lotfinia M; Motedayyen H
    Int J Immunopathol Pharmacol; 2022; 36():3946320221078476. PubMed ID: 35226515
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenotype and function of CXCR5+CD45RA-CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis.
    Duan Z; Gao J; Zhang L; Liang H; Huang X; Xu Q; Zhang Y; Shen T; Lu F
    Oncotarget; 2015 Dec; 6(42):44239-53. PubMed ID: 26517519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
    Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
    Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma.
    Hung YP; Shao YY; Hsu C; Hsu CH; Lee JM; Yang MH; Chao Y
    J Formos Med Assoc; 2021 Aug; 120(8):1581-1590. PubMed ID: 33334658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus.
    Abdelwahab FA; Hassanein KM; Hetta HF; Abdelmalek MO; Zahran AM; El-Badawy O
    Sci Rep; 2020 Nov; 10(1):20383. PubMed ID: 33230233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased frequency of CD4+CD25(high)FoxP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Feng X; Li B; Ye H; Long D
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):309-14. PubMed ID: 21633918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival.
    Qin SK; Li Q; Ming Xu J; Liang J; Cheng Y; Fan Y; Jiang J; Ye H; Tao H; Li L; Zheng L; Wei Z; Li S; Meng K; Ye B; Sun Y
    Cancer Sci; 2020 Nov; 111(11):4218-4231. PubMed ID: 32889778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma.
    Fan J; Li J; Han J; Zhang Y; Gu A; Song F; Duan J; Yin D; Wang L; Yi Y
    Mol Immunol; 2021 Aug; 136():82-97. PubMed ID: 34098344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-35 Suppresses Interleukin-9-Secreting CD4
    Zhang Q; Yang L; Liu S; Zhang M; Jin Z
    Front Immunol; 2021; 12():645835. PubMed ID: 34177894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-24 Limits Tumor-Infiltrating T Helper 17 Cell Response in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Zhang M; Zhao H; Gao H
    Viral Immunol; 2022 Apr; 35(3):212-222. PubMed ID: 35099297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.
    Ormandy LA; Hillemann T; Wedemeyer H; Manns MP; Greten TF; Korangy F
    Cancer Res; 2005 Mar; 65(6):2457-64. PubMed ID: 15781662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-35 suppresses the activity of natural killer-like B cells in patients with hepatocellular carcinoma.
    Liu S; Yang L; Jia S; Zhao R; Jin Z
    Int Immunopharmacol; 2021 Nov; 100():108161. PubMed ID: 34555643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T Cells, IL10 and IL6 in HCV Related Hepatocellular Carcinoma after Transarterial Chemoembolization (TACE).
    Hassan EA; Ahmed EH; Nafee AM; El-Gafary N; Hetta HF; El-Mokhtar MA
    Egypt J Immunol; 2019 Jan; 26(1):69-78. PubMed ID: 31332997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prognostic value of cellular immunity function in patients with hepatocellular carcinoma].
    Kong L; Yao SK; Liu JX; Wang N
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):194-7. PubMed ID: 15760554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection.
    Kakumu S; Ito S; Ishikawa T; Mita Y; Tagaya T; Fukuzawa Y; Yoshioka K
    J Gastroenterol Hepatol; 2000 Apr; 15(4):431-6. PubMed ID: 10824889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.